Home
Sandoz

Sandoz Market Share Analysis for May 2026

Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz.

Health > Biotechnology and Pharmaceuticals

Domainsandoz.com

Year Founded1886

Employees> 10001

Annual Revenue> $1B

Sandoz

Sandoz (including company regionals)

sandoz.com

See more website traffic and engagement information

Sandoz Revenue up to May 2026 is > 1B

revenue generated by Sandoz top domains

Sandoz top domains revenue over 3 years

Revenue for Sandoz top domains

sandoz.com> 1B

See more with Sales Intelligence

Total visits to Sandoz's top domains

Understand Sandoz market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

sandoz.com330.2K

See more with Sales Intelligence

Avg. visit duration in Sandoz's top domains

Analyze Sandoz engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

sandoz.com00:00:43

See more with Sales Intelligence

Avg. pageviews on Sandoz's top domains

See how Sandoz keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

sandoz.com2.04

See more with Sales Intelligence

Sandoz top competitors by domain

Top similar sites in May 2026, ranked by their affinity

hikma.comCompany NameHikma Pharmaceuticals PLCEmployees5001 - 10000HQUnited Kingdom, LondonAnnual revenue> $1BTotal visits197.2KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Sandoz

These are the website technologies, by industry, used by Sandoz top domains

Social (5)

Instagram

Advertising (4)

DoubleClick

Conversion & Analytics (4)

Google Analytics

Audio Video Media (3)

YouTube

More Technologies

10

See all

News & Signals from Sandoz

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSandoz invests into assets: centre in the amount of $99M in Ljubljana, Slovenia, Southern Europe, Europe.The newly opened centre is the first of three major investment projects, forming part of Sandoz total investment of more than USD 1.1 billion in Slovenia, creating an end-to-end in-house biosimilar development and manufacturing hub in Europe.

NewsSandoz expanded facilities to Slovenia, Southern Europe, Europe on Jun 17th '26.The Swiss pharma group Sandoz has inaugurated a US$99 million biosimilars development centre in Ljubljana, the first of its three major investment projects in Slovenia to create an end-to-end in-house biosimilar development and manufacturing hub in Europe.